Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Gow

Showing results (11-20 of 85) with videos related to

Pageof 9
Sort By:
BMJ Case Reports|September 28, 2017
Efficacy of oral vancomycin in recurrent primary sclerosing cholangitis following liver transplantationPenelope Hey, Julie Lokan, Paul Johnson, et al.
Journal of Gastroenterology and Hepatology|February 26, 2013
Toll-like receptors in hepatitis C infection: implications for pathogenesis and treatmentJessica Howell, Peter Angus, Paul Gow, et al.
Clinical Case Reports|September 3, 2015
Fulminant hepatic failure after intravenous injection of sublingual buprenorphine in a patient with hepatitis CJanine French, Avik Mujumdar, Peter Angus, et al.
Hepatology (Baltimore, Md.)|December 25, 2009
A case of fulminant hepatic failure in pregnancyJohn Halliday, Julie Lokan, Peter W Angus, et al.
Hepatology (Baltimore, Md.)|November 30, 2019
Letter to the Editor: Moderate Alcohol Use in Fatty Liver Disease: Don't Throw the Cabernet Out With the BathwaterPaul Gow, Adam G Testro, Penelope Hey, et al.
Hepatology (Baltimore, Md.)|November 3, 2015
Efficacy of outpatient continuous terlipressin infusions for hepatorenal syndromeAbhinav Vasudevan, Zaid Ardalan, Paul Gow, et al.
Journal of Gastroenterology and Hepatology|April 20, 2005
Association of fulminant non-A non-B hepatitis with homozygosity for HLA A1-B8-DR3Paul Gow, Mark Hathaway, Bridget Gunson, et al.
Nutrients|January 11, 2024
Portal Hypertension in Malnutrition and Sarcopenia in Decompensated Cirrhosis-Pathogenesis, Implications and Therapeutic OpportunitiesRyma Terbah, Adam Testro, Paul Gow, et al.
Alimentary Pharmacology & Therapeutics|August 15, 2020
Estimates of the global reduction in liver disease-related mortality with increased coffee consumption: an analysis of the Global Burden of Disease DatasetPaul Gow, Tim Spelman, Sarah Gardner, et al.
Inflammatory Bowel Diseases|February 21, 2020
Letter Re: Safety of Combination Biologic and Antirejection Therapy Post-liver Transplantation in Patients With Inflammatory Bowel DiseaseMatthew Peverelle, Chris Mills, Adam Testro, et al.
Pageof 9

Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
BMJ Case Reports|September 28, 2017
Efficacy of oral vancomycin in recurrent primary sclerosing cholangitis following liver transplantationPenelope Hey, Julie Lokan, Paul Johnson, et al.
Journal of Gastroenterology and Hepatology|February 26, 2013
Toll-like receptors in hepatitis C infection: implications for pathogenesis and treatmentJessica Howell, Peter Angus, Paul Gow, et al.
Clinical Case Reports|September 3, 2015
Fulminant hepatic failure after intravenous injection of sublingual buprenorphine in a patient with hepatitis CJanine French, Avik Mujumdar, Peter Angus, et al.
Hepatology (Baltimore, Md.)|December 25, 2009
A case of fulminant hepatic failure in pregnancyJohn Halliday, Julie Lokan, Peter W Angus, et al.
Hepatology (Baltimore, Md.)|November 30, 2019
Letter to the Editor: Moderate Alcohol Use in Fatty Liver Disease: Don't Throw the Cabernet Out With the BathwaterPaul Gow, Adam G Testro, Penelope Hey, et al.
Hepatology (Baltimore, Md.)|November 3, 2015
Efficacy of outpatient continuous terlipressin infusions for hepatorenal syndromeAbhinav Vasudevan, Zaid Ardalan, Paul Gow, et al.
Journal of Gastroenterology and Hepatology|April 20, 2005
Association of fulminant non-A non-B hepatitis with homozygosity for HLA A1-B8-DR3Paul Gow, Mark Hathaway, Bridget Gunson, et al.
Nutrients|January 11, 2024
Portal Hypertension in Malnutrition and Sarcopenia in Decompensated Cirrhosis-Pathogenesis, Implications and Therapeutic OpportunitiesRyma Terbah, Adam Testro, Paul Gow, et al.
Alimentary Pharmacology & Therapeutics|August 15, 2020
Estimates of the global reduction in liver disease-related mortality with increased coffee consumption: an analysis of the Global Burden of Disease DatasetPaul Gow, Tim Spelman, Sarah Gardner, et al.
Inflammatory Bowel Diseases|February 21, 2020
Letter Re: Safety of Combination Biologic and Antirejection Therapy Post-liver Transplantation in Patients With Inflammatory Bowel DiseaseMatthew Peverelle, Chris Mills, Adam Testro, et al.
Pageof 9